Impact on work productivity in unresectable locally advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma patients and their caregivers

被引：0
|
作者：
Xiao, H. [1 ]
Hall, J. P. [2 ]
Khela, K. [2 ]
Moon, R. [2 ]
Bertwistle, D. [3 ]
机构：
[1] BMS, Worldwide Hlth Econ & Outcomes Res Oncol, New Brunswick, NJ USA
[2] Adelphi Real World, Oncol, Bollington, England
[3] BMS, Worldwide Hlth Econ & Outcomes Res Oncol, Uxbridge, Middx, England
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1939
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1433P
引用
收藏
页码：S904 / S904
页数：1
相关论文
共 50 条
  • [1] DIRECT AND INDIRECT COSTS ASSOCIATED WITH UNRESECTABLE ADVANCED OR METASTATIC (ADV/MET) GASTRIC CANCER (GC), GASTROESOPHAGEAL JUNCTION CANCER (GEJC) AND ESOPHAGEAL ADENOCARCINOMA (EAC) FOR PATIENTS AND THEIR CAREGIVERS
    Hall, J.
    Khela, K.
    Bertwistle, D.
    Xiao, H.
    [J]. VALUE IN HEALTH, 2020, 23 : S482 - S483
  • [2] Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
    Ratosa, Ivica
    Oblak, Irena
    Anderluh, Franc
    Velenik, Vaneja
    But-Hadzic, Jasna
    Ermenc, Ajra Secerov
    Jeromen, Ana
    [J]. RADIOLOGY AND ONCOLOGY, 2015, 49 (02) : 163 - 172
  • [3] PREOPERATIVE TREATMENT WITH RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED GASTROESOPHAGEAL JUNCTION (GEJ) CANCER AND UNRESECTABLE LOCALLY ADVANCED GASTRIC CANCER
    Irena, Oblak
    Franc, Anderluh
    Vaneja, Velenik
    Jasna, But-Hadzic
    Ajra, Secerov-Ermenc
    Ana, Jeromen
    Ivica, Ratosa
    [J]. ANNALS OF ONCOLOGY, 2014, 25 : 45 - 45
  • [4] The humanistic burden reported by patients with unresectable locally advanced or metastatic (adv/met) gastric cancer (GC), gastroesophageal junction cancer (GEJC) and esophageal adenocarcinoma (EAC): An international real-world survey
    Hall, J. P.
    Khela, K.
    Moon, R.
    Middleton-Dalby, C.
    Bertwistle, D.
    Xiao, H.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S918 - S918
  • [5] Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
    Shitara, Kohei
    Xu, Rui-Hua
    Ajani, Jaffer A.
    Moran, Diarmuid
    Guerrero, Abraham
    Li, Ran
    Pavese, Janet
    Matsangou, Maria
    Bhattacharya, Pranob
    Ueno, Yoko
    Wang, Xuewei
    Shah, Manish A.
    [J]. GASTRIC CANCER, 2024, 27 (05) : 1058 - 1068
  • [6] Pembrolizumab for first-line treatment of advanced unresectable or metastatic esophageal or gastroesophageal junction cancer
    Hirose, Toshiharu
    Yamamoto, Shun
    Kato, Ken
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [7] Efficacy and safety of infigratinib in locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients with FGFR2 gene amplification
    Yuan, J.
    Shen, L.
    Liu, T.
    Xu, H.
    Yang, J.
    Wei, J.
    Jiang, H.
    Deng, Y.
    Wang, Y.
    Zhang, X.
    Gong, J.
    Lyu, C.
    Li, Y.
    Song, L.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S859 - S860
  • [8] Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
    Bang, Yung-Jue
    Cho, Jae Yong
    Kim, Yeul Hong
    Kim, Jin Won
    Di Bartolomeo, Maria
    Ajani, Jaffer A.
    Yamaguchi, Kensei
    Balogh, Agnes
    Sanchez, Teresa
    Moehler, Markus
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5671 - 5678
  • [9] Best Practices for Managing Patients with Unresectable Metastatic Gastric and Gastroesophageal Junction Cancer in Canada
    Snow, Stephanie
    Gabrielson, Denise
    Lim, Howard
    Tehfe, Mustapha
    Brezden-Masley, Christine
    [J]. CURRENT ONCOLOGY, 2024, 31 (05) : 2552 - 2565
  • [10] Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
    Peng, Zhi
    Li, Zhongwu
    Gao, Jing
    Lu, Ming
    Gong, Jifang
    Tang, En-Tzu
    Oliner, Kelly S.
    Hei, Yong-Jiang
    Zhou, Hui
    Shen, Lin
    [J]. MOLECULAR CANCER THERAPEUTICS, 2015, 14 (11) : 2634 - 2641
12345